Trademark: EZ SPERSE 1714039
Word
EZ SPERSE
ID
1714039
Trademark Type
WORD
Status
Protected: Renewal due
Application Date
28 May 2015
Registration Date
28 May 2015
Renewal Date
28 May 2025
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 5:
Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual disfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; all included in class 5
Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual disfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; all included in class 5